The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53

por Reuland, Steven N., Goldstein, Nathaniel B., Partyka, Katie A., Cooper, David A., Fujita, Mayumi, Norris, David A., Shellman, Yiqun G.
Publicado 2011

Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9

por Tang, Huiyuan, Partyka, Katie, Hsueh, Peter, Sinha, Jessica Y., Kletter, Doron, Zeh, Herbert, Huang, Ying, Brand, Randall E., Haab, Brian B.
Publicado 2015

Detection of distinct glycosylation patterns on human γ-glutamyl transpeptidase 1 using antibody-lectin sandwich array (ALSA) technology

por West, Matthew B, Partyka, Katie, Feasley, Christa L, Maupin, Kevin A, Goppallawa, Indiwari, West, Christopher M, Haab, Brian B, Hanigan, Marie H
Publicado 2014

The Marker State Space (MSS) Method for Classifying Clinical Samples

por Fallon, Brian P., Curnutte, Bryan, Maupin, Kevin A., Partyka, Katie, Choi, Sunguk, Brand, Randall E., Langmead, Christopher J., Tembe, Waibhav, Haab, Brian B.
Publicado 2013

The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells

por Barnett, Daniel, Liu, Ying, Partyka, Katie, Huang, Ying, Tang, Huiyuan, Hostetter, Galen, Brand, Randall E., Singhi, Aatur D., Drake, Richard R., Haab, Brian B.
Publicado 2017

ABT-737 synergizes with Bortezomib to kill melanoma cells

por Reuland, Steven N., Goldstein, Nathaniel B., Partyka, Katie A., Smith, Shilo, Luo, Yuchun, Fujita, Mayumi, Gonzalez, Rene, Lewis, Karl, Norris, David A., Shellman, Yiqun G.
Publicado 2011

MicroRNA-26a is Strongly Down-regulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD)

por Reuland, Steven N., Smith, Shilo, Bemis, Lynne, Goldstein, Nathaniel B., Almeida, Adam, Partyka, Katie A, Marquez, Victor E., Zhang, Qinghong, Norris, David A., Shellman, Yiqun G.
Publicado 2012

A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas

por Sinha, Jessica, Cao, Zheng, Dai, Jianliang, Tang, Huiyuan, Partyka, Katie, Hostetter, Galen, Simeone, Diane M., Feng, Ziding, Allen, Peter J., Brand, Randall E., Haab, Brian B.
Publicado 2016

Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers

por Yue, Tingting, Maupin, Kevin A., Fallon, Brian, Li, Lin, Partyka, Katie, Anderson, Michelle A., Brenner, Dean E., Kaul, Karen, Zeh, Herbert, Moser, A. James, Simeone, Diane M., Feng, Ziding, Brand, Randall E., Haab, Brian B.
Publicado 2011

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments

por Mukherjee, Nabanita, Almeida, Adam, Partyka, Katie A., Lu, Yan, Schwan, Josianna V., Lambert, Karoline, Rogers, Madison, Robinson, William A, Robinson, Steven E, Applegate, Allison J, Amato, Carol M, Luo, Yuchun, Fujita, Mayumi, Norris, David A., Shellman, Yiqun G.
Publicado 2016

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens

por Haab, Brian B., Huang, Ying, Balasenthil, Seetharaman, Partyka, Katie, Tang, Huiyuan, Anderson, Michelle, Allen, Peter, Sasson, Aaron, Zeh, Herbert, Kaul, Karen, Kletter, Doron, Ge, Shaokui, Bern, Marshall, Kwon, Richard, Blasutig, Ivan, Srivastava, Sudhir, Frazier, Marsha L., Sen, Subrata, Hollingsworth, Michael A., Rinaudo, Jo Ann, Killary, Ann M., Brand, Randall E.
Publicado 2015